DUBLIN–(BUSINESS WIRE)–The “Inhaled Drugs Contract Manufacturing Market Forecast to 2033” has been added to ResearchAndMarkets.com’s offering. The global inhaled drugs contract manufacturing market is experiencing significant growth, with its size projected to increase from USD 5.47 billion in 2024 to USD 12.56 billion by 2033. The market is set to grow at a compound annual growth rate (CAGR) of 9.82% from 2025 to 2033. This expansion is primarily driven by an increasing prevalence of respira
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/lonza-group-catalent-and-recipharm-lead-the-12-5-billion-inhaled-drugs-contract-manufacturing-market-2025-2033-insights-by-service-product-end-use-and-region-researchandmarkets-com/
